Search research articles
Contact Us
Filters
Showing results (1311-1320 of 1,489) with videos related to
Page
of 149
Sort By:
Cancer Discovery
|
October 1, 2013
A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors
Nadine S Jahchan, Joel T Dudley, Pawel K Mazur, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 19, 2021
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50
Martin Reck, Delvys Rodríguez-Abreu, Andrew G Robinson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 29, 2018
Understanding the role of genetic variability in LRRK2 in Indian population
Asha Kishore, Ashwin Ashok Kumar Sreelatha, Marc Sturm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 18, 2017
CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial
Marianne Sinn, Marcus Bahra, Torsten Liersch, et al.
Brain : a Journal of Neurology
|
February 16, 2013
A progressive dopaminergic phenotype associated with neurotoxic conversion of α-synuclein in BAC-transgenic rats
Silke Nuber, Florian Harmuth, Zacharias Kohl, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
March 7, 2008
Neurodegeneration and motor dysfunction in a conditional model of Parkinson's disease
Silke Nuber, Elisabeth Petrasch-Parwez, Beate Winner, et al.
Ebiomedicine
|
April 16, 2021
A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: Results from the CONKO-005 trial
K Hoyer, R Hablesreiter, Y Inoue, et al.
Neurology
|
September 17, 2017
Analysis of blood-based gene expression in idiopathic Parkinson disease
Ron Shamir, Christine Klein, David Amar, et al.
Breast (Edinburgh, Scotland)
|
May 22, 2025
Clinical genome sequencing in patients with hereditary breast and ovarian cancer: Concept, implementation and benefits
Dennis Witt, Marc Sturm, Antje Stäbler, et al.
Brain : a Journal of Neurology
|
October 23, 2015
Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD rat
Laura E Clemens, Jonasz J Weber, Tanja T Wlodkowski, et al.
Page
of 149
Search research articles
Search
Showing results (1311-1320 of 1,489) with videos related to
Sort By:
Page
of 149
Cancer Discovery
|
October 1, 2013
A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors
Nadine S Jahchan, Joel T Dudley, Pawel K Mazur, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 19, 2021
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50
Martin Reck, Delvys Rodríguez-Abreu, Andrew G Robinson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 29, 2018
Understanding the role of genetic variability in LRRK2 in Indian population
Asha Kishore, Ashwin Ashok Kumar Sreelatha, Marc Sturm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 18, 2017
CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial
Marianne Sinn, Marcus Bahra, Torsten Liersch, et al.
Brain : a Journal of Neurology
|
February 16, 2013
A progressive dopaminergic phenotype associated with neurotoxic conversion of α-synuclein in BAC-transgenic rats
Silke Nuber, Florian Harmuth, Zacharias Kohl, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
March 7, 2008
Neurodegeneration and motor dysfunction in a conditional model of Parkinson's disease
Silke Nuber, Elisabeth Petrasch-Parwez, Beate Winner, et al.
Ebiomedicine
|
April 16, 2021
A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: Results from the CONKO-005 trial
K Hoyer, R Hablesreiter, Y Inoue, et al.
Neurology
|
September 17, 2017
Analysis of blood-based gene expression in idiopathic Parkinson disease
Ron Shamir, Christine Klein, David Amar, et al.
Breast (Edinburgh, Scotland)
|
May 22, 2025
Clinical genome sequencing in patients with hereditary breast and ovarian cancer: Concept, implementation and benefits
Dennis Witt, Marc Sturm, Antje Stäbler, et al.
Brain : a Journal of Neurology
|
October 23, 2015
Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD rat
Laura E Clemens, Jonasz J Weber, Tanja T Wlodkowski, et al.
Page
of 149